[Federal Register Volume 78, Number 175 (Tuesday, September 10, 2013)]
[Notices]
[Pages 55259-55260]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-21974]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60-Day-13-0199]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-7570
and send comments to LeRoy Richardson, 1600 Clifton Road, MS-D74,
Atlanta, GA 30333 or send an email to [email protected].
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should
[[Page 55260]]
be received within 60 days of this notice.
Proposed Project: Importation of Etiologic Agents (42 CFR 71.54)
(OMB Control No. 0920-0199, exp. 1/31/2014)--Revision--Office of Public
Health Preparedness and Response (OPHPR), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Section 361 of the Public Health Service Act (42 U.S.C. 264), as
amended, authorizes the Secretary of Health and Human Services to make
and enforce such regulations as are necessary to prevent the
introduction, transmission, or spread of communicable diseases from
foreign countries into the States or possessions, or from one State or
possession into any other State or possession. Part 71 of Title 42,
Code of Federal Regulations (Foreign Quarantine) sets forth provisions
to prevent the introduction, transmission, and spread of communicable
disease from foreign countries into the United States. Subpart F--
Importations--contains provisions for the importation of infectious
biological agents, infectious substances, and vectors (42 CFR 71.54);
requiring persons that import these materials to obtain a permit issued
by the CDC.
CDC requests Office of Management and Budget approval to collect
information for three years using the Application for Permit to Import
Biological Agents, Infectious Substances and Vectors of Human Disease
into the United States and Application for a Permit to Import or
Transport Live Bats. We are also requesting a title change to read--
Application for Permit to Import Infectious Biological Agents into the
United States (42 CFR 71.54.
The Application for Permit to Import Biological Agents, Infectious
Substances and Vectors of Human Disease into the United States form is
used by laboratory facilities, such as those operated by government
agencies, universities, and research institutions to request a permit
for the importation of biological agents, infectious substances, or
vectors of human disease. This form currently requests applicant and
sender contact information; description of material for importation;
facility isolation and containment information; and personnel
qualifications. CDC plans to revise this application to request
information on where the imported material will be stored at the
recipient facility and who would be responsible for this location;
verification that the permittee has implemented biosafety measures
commensurate with the hazard posed by the infectious biological agent,
infectious substance, and/or vector to be imported, and the level of
risk given its intended use; and a secondary contact information for
the permittee to provide in case the permittee is unavailable. These
additional data requests will not affect the burden hours.
The Application for Permit to Import or Transport Live Bats form is
used by laboratory facilities such as those operated by government
agencies, universities, research institutions, and for educational,
exhibition, or scientific purposes to request a permit for the
importation, and any subsequent distribution after importation, of live
bats. This form currently requests the applicant and sender contact
information; a description and intended use of bats to be imported; and
facility isolation and containment information. CDC plans to revise
this application to request secondary contact information for the
permittee to provide in case the permittee is unavailable. These
additional data requests will not affect the burden hours.
Estimates of burden for the survey are based on information
obtained from the CDC import permit database on the number of permits
issued on annual basis since 2010. The total estimated burden for the
one-time data collection is 545 hours.
There are no costs to respondents except their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Applicants Requesting to Application for 1,625 1 20/60 542
Import Biological Agents, Permit to
Infectious Substances and Import
Vectors. Biological
Agents,
Infectious
Substances and
Vectors of
Human Disease
into the United
States.
Applicants Requesting to Application for 10 1 20/60 3
Import Live Bats. a Permit to
Import Live
Bats.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 545
----------------------------------------------------------------------------------------------------------------
LeRoy Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2013-21974 Filed 9-9-13; 8:45 am]
BILLING CODE 4163-18-P